Roivant Sciences (ROIV) Capital Expenditures (2020 - 2025)

Roivant Sciences' Capital Expenditures history runs 6 years deep, the most recent figure standing at $6.9 million for Q4 2025.

• Quarterly Capital Expenditures rose 83.42% year-over-year to $6.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $22.6 million (up 233.52% YoY) and the FY2026 annual result came in at $7.4 million, up 61.25% from the prior year.
• Capital Expenditures was $6.9 million for Q4 2025 at Roivant Sciences, down from $7.8 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $11.2 million in Q4 2021 and bottomed at $275000.0 in Q3 2023.
• A 5-year average of $4.3 million and a median of $3.1 million in 2022 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2023 — Capital Expenditures sank 94.6% — and 2025, when it soared 687.95%.
• Roivant Sciences' Capital Expenditures stood at $11.2 million in 2021, then retreated by 0.94% to $11.1 million in 2022, then sank by 90.67% to $1.0 million in 2023, then jumped by 266.7% to $3.8 million in 2024, then surged by 83.42% to $6.9 million in 2025.
• Business Quant data shows ROIV's Capital Expenditures at $6.9 million in Q4 2025, $7.8 million in Q3 2025, and $4.0 million in Q2 2025.